[Skip To Content]
[Website of the National Cancer Institute's Technology Transfer Center.  Partnering with Industry for Improved Public Health.]
  • Home
  • Collaborative Opportunities
  • Standard Forms and Agreements
  • Technology Transfer Training
  • Resources
  • Intellectual Property

Imaging Agents to Monitor the Distribution of Therapies Delivered to the Brain

Background:
The National Institute of Neurological Disorders and Stroke (NINDS) seeks a commercial collaborator to work with NINDS in the development and commercialization of surrogate markers for monitoring the spatial distribution of therapeutic substances by MRI or CT that have been administered to tissue of the brain using Convection Enhanced Delivery (CED).

Technology:
The macromolecular imaging agents have clearance properties that mimic the pharmacokinetic properties of co-administrated drugs, so as to be useful in quantifying the range and dosage level of therapeutic drugs using MR imaging.

Potential Areas of Application:
Delivery of various therapeutic compounds that otherwise would not pass the blood brain barrier

Main Advantages of Technology/Invention:
  • Increases the breadth of compounds available for treatment of diseases and disorders of the brain.
  • Improves the utilization of CED in delivering drugs to the brain.
Current State of Development:
  • CED in use by multiple research and medical facilities
  • Non-human primate imaging studies completed
  • cGMP-grade compound in development
Further R&D Required:
  • Development of additional markers
  • Additional clinical trials
IP Status:
Patent pending

Contact Information:
Laurie Arrants
Technology Development Coordinator, NINDS
Phone: 301-435-3120
E-mail: ArrantsL@ninds.nih.gov

Reference:  #211 LA

Updated 04/03/2008

This opportunity is also listed under the following categories:


E-MAIL SERVICE

TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.

Page Last Updated: 12-17-2008